Cardiovascular diseases (CVDs), principally ischemic heart disease (IHD) and stroke, are
the leading cause of global mortality and a major contributor to disability. This paper reviews …

The global nephrology community recognises the need for a cohesive plan to address the
problem of chronic kidney disease (CKD). In July, 2016, the International Society of …

Background Cardiovascular disease, which includes coronary artery disease, stroke and
peripheral vascular disease, is a leading cause of death worldwide. Homocysteine is an amino …

Background There is no standard treatment for unresectable hepatocellular carcinoma. Arterial
embolisation is widely used, but evidence of survival benefits is lacking. Methods We did …

Methods. Of the 868 patients enrolled in APRICOT, 832 were included in the analysis. Thirty‐six
patients were excluded because of lack of interpretable histology. Liver histology was …

Background In phase 2 trials, telaprevir, a hepatitis C virus (HCV) genotype 1 protease
inhibitor, in combination with peginterferon–ribavirin, as compared with peginterferon–ribavirin …

Background The cutaneous manifestations of COVID‐19 disease are poorly characterized.
Objectives To describe the cutaneous manifestations of COVID‐19 disease and to relate …

The present outbreak of lower respiratory tract infections, including respiratory distress
syndrome, is the third spillover, in only two decades, of an animal coronavirus to humans …

Pool surveys the legal history of the different modes of communication--print, carrier and
broadcasting--and shows how the constitutional tradition of a free press and free speech was …

Molecular typing based on 12 loci containing variable numbers of tandem repeats of
mycobacterial interspersed repetitive units (MIRU-VNTRs) has been adopted in combination with …